Instem Acquires Market Leader d-wise to Further Accelerate Life Science Development

Instem’s Acquisition of Leading Clinical Trial Technology and Consulting Provider d-wise Represents Substantial Advancement of its Mission

PHILADELPHIA, PA – (BUSINESS WIRE) – March 22, 2021 - Instem, a leading provider of IT solutions and services to the global life sciences market, announced today that it has acquired clinical trial technology and consulting leader d-wise, Inc. (d-wise) as part of its mission to enable clients to bring their life enhancing products to market faster. The further consolidation of key application areas will help customers streamline and accelerate their research and development processes, while access to a broader range of data from across the R&D continuum will increase the power of future in silico modelling and prediction solutions.

Instem’s Coronavirus (COVID-19) Response

April 20, 2020 - Please read our latest update on how we’re helping clients fight the COVID-19 pandemic.